Patents by Inventor Martin Indarte

Martin Indarte has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds, compositions and methods for inhibiting CNKSR1
    Patent number: 10227356
    Abstract: Compounds that inhibit CNKSR1, pharmaceutical compositions including compounds that inhibit CNKSR1 and methods of treating disease or disorders that respond to CNKSR1 inhibition are described herein. Additionally, methods of identifying inhibitors of CNKSR1 are described.
    Type: Grant
    Filed: April 20, 2016
    Date of Patent: March 12, 2019
    Assignee: PHUSIS THERAPEUTICS, INC.
    Inventors: D. Lynn Kirkpatrick, Martin Indarte
  • COMPOUNDS, COMPOSITIONS AND METHODS FOR INHIBITING CNKSR1
    Publication number: 20160304533
    Abstract: Compounds that inhibit CNKSR1, pharmaceutical compositions including compounds that inhibit CNKSR1 and methods of treating disease or disorders that respond to CNKSR1 inhibition are described herein. Additionally, methods of identifying inhibitors of CNKSR1 are described.
    Type: Application
    Filed: April 20, 2016
    Publication date: October 20, 2016
    Applicant: Phusis Therapeutics, Inc.
    Inventors: D. Lynn KIRKPATRICK, Martin INDARTE
  • Methods and compositions for inhibiting CNKSR1
    Patent number: 9340532
    Abstract: Embodiments include compositions and methods of inhibiting CNKSR1 and methods of identifying inhibitors of CNKSR1.
    Type: Grant
    Filed: December 16, 2013
    Date of Patent: May 17, 2016
    Assignee: Phusis Therapeutics, Inc.
    Inventors: D. Lynn Kirkpatrick, Martin Indarte, Nathan T. Ihle
  • METHODS AND COMPOSITIONS FOR INHIBITING CNKSR1
    Publication number: 20150307482
    Abstract: Embodiments include compositions and methods of inhibiting CNKSR1 and methods of identifying inhibitors of CNKSR1.
    Type: Application
    Filed: December 16, 2013
    Publication date: October 29, 2015
    Applicant: PHUSIS THERAPEUTICS, INC.
    Inventors: D. LYNN KIRKPATRICK, MARTIN INDARTE, NATHAN T. IHLE
  • Cocaine Antagonist/Antidepressant Pharmaceutical Preparations
    Publication number: 20120322824
    Abstract: The present invention is a psychostimulant antagonist or antidepressant in pharmaceutical unit dosage form—with each unit dosage form containing in an effective amount to treat cocaine or amphetamine dependence in an animal or human in which such treatment is indicated and to whom one or more such unit dosage forms are administered—comprising one or more substituted or unsubstituted diphenyl piperidine derivative active agents according to Formula I: including a diastereomer or enantiomer thereof, together with one or more pharmaceutically acceptable excipients or diluents.
    Type: Application
    Filed: December 14, 2011
    Publication date: December 20, 2012
    Inventors: Christopher K. Surratt, Jeffry D. Madura, Martin Indarte, David Lapinsky, Jeffery Talbot